Clinical trial
THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation
NCT00578695 is registered in ClinicalTrials.gov with CardioKine Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation
- Lead sponsor
- CardioKine Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- Not reported
- Enrollment
- 652 (actual)
- Sites
- 287
Conditions
As the registry lists them; a condition with its own page is linked.